Arie Belldegrun raises $300M, grabs Pfizer’s allogeneic CAR-T portfolio and launches a groundbreaking drive to commercialization admin April 4, 2018 PR You Might Also Like Annual Biomed Confab Highlights Role Of Advanced Tech In Rehabilitation May 14, 2019 5 Israeli startups seeking cures for rare genetic diseases May 14, 2018 Call for companies to present their activities in MIXiii-BIOMED 2018 (Hebrew) March 25, 2018
